Glen Santangelo Credit Suisse

Climbing from runner-up to third place is Credit Suisse’s Glen Santangelo, who wins the gratitude of one investor because “his Omnicare downgrade saved us an expensive loss.” Santangelo reduced the Covington, Kentucky–based long-term care pharmacy from outperform to neutral in July, at $24.78, because he saw shifting reimbursement rates pushing generics use higher — and pharmacy margins lower. The stock had tumbled 22.5 percent, to $19.20, by the end of August.